AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

PERCHERON FPO

0.005

0.000-9.09%

Volume:258.33K

Turnover:1K

Market Cap:7.61M

PE:-0.62

High:0.005

Open:0.005

Low:0.005

Close:0.006

52wk High:0.011

52wk Low:0.002

Shares:1.52B

Float Shares:816.63M

Volume Ratio:0.03

T/O Rate:0.03%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.008

EPS(LYR):-0.004

ROE:-54.66%

ROA:-28.90%

PB:1.01

PE(LYR):-1.22

Loading ...

Overview Company News Filings

Percheron Therapeutics - James Garner to Step Down as CEO and Managing Director

THOMSON REUTERS

Percheron Therapeutics Ltd-Who Selects Proposed Inn for Hmbd-002

THOMSON REUTERS

Is This Singapore Mid-Cap Stock a 10-Bagger in the Making

The Smart Investor

CEO, MD & Director of Percheron Therapeutics James Garner Buys 40% More Shares

Simply Wall St.

Percheron Therapeutics Ltd-Results of Entitlement Offer

THOMSON REUTERS

Bali Airport Records 1% Raise in Passengers During 2026 Eid Holiday

BRIEF-Percheron Therapeutics To Raise Up To A$2.2 Million

Percheron Therapeutics Ltd-Non-Renounceable Entitlement Offer

THOMSON REUTERS

Percheron Therapeutics Ltd - Issue Price Set at a$0.005 per Share

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/PER.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PER.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"PER.AU\",,,,,undefined,":{"symbol":"PER.AU","market":"AU","secType":"STK","nameCN":"PERCHERON FPO","latestPrice":0.005,"timestamp":1787292720000,"preClose":0.0055,"halted":0,"volume":258333,"delay":0,"changeRate":-0.09090909090909084,"nameEN":"PERCHERON FPO","floatShares":816628906,"shares":1522412686,"eps":-0.008,"marketStatus":"Market Closed","change":-0.0005,"latestTime":"08-21 16:12:00 AEST","open":0.005,"high":0.005,"low":0.005,"amount":1292,"amplitude":0,"askPrice":0.006,"askSize":8804293,"bidPrice":0.005,"bidSize":12690314,"shortable":3,"etf":0,"ttmEps":-0.008,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787529600000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.0055,"openAndCloseTimeList":[[1787270400000,1787292000000]],"volumeRatio":0.03240601092689542,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"PER.AU","preClose":0.005,"auctionPrice":0.005,"auctionVolume":956843,"auction":3,"marketStatus":"盘后竞价","timestamp":1786947006465}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"PER.AU\",,,,,undefined,":{"symbol":"PER.AU","floatShares":816628906,"roa":"-28.90%","roe":"-54.66%","lyrEps":-0.0041,"volumeRatio":0.03240601092689542,"shares":1522412686,"dividePrice":0,"high":0.005,"amplitude":0,"preClose":0.0055,"low":0.005,"week52Low":0.002,"pbRate":"1.01","psRate":"9.02","week52High":0.011,"institutionHeld":0,"latestPrice":0.005,"committee":0.180791,"eps":-0.008,"divideRate":0,"volume":258333,"delay":0,"ttmEps":-0.008,"open":0.005,"prevYearClose":0.009,"prevWeekClose":0.005,"prevMonthClose":0.003,"prevQuarterClose":0.003,"fiveDayClose":0.005,"twentyDayClose":0.003,"sixtyDayClose":0.005},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PER.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PER.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PER.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658460369","title":"Percheron Therapeutics - James Garner to Step Down as CEO and Managing Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2658460369","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658460369?lang=en_us&edition=fundamental","pubTime":"2026-08-10 06:24","pubTimestamp":1786314263,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260809:nFWN44600H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","PER.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638568078","title":"Percheron Therapeutics Ltd-Who Selects Proposed Inn for Hmbd-002","url":"https://stock-news.laohu8.com/highlight/detail?id=2638568078","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638568078?lang=en_us&edition=fundamental","pubTime":"2026-05-26 07:22","pubTimestamp":1779751360,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260525:nTUESGV1R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PER.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637804468","title":"Is This Singapore Mid-Cap Stock a 10-Bagger in the Making","url":"https://stock-news.laohu8.com/highlight/detail?id=2637804468","media":"The Smart Investor","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637804468?lang=en_us&edition=fundamental","pubTime":"2026-05-21 14:00","pubTimestamp":1779343200,"startTime":"0","endTime":"0","summary":"Finding a “10-bagger” is every investor’s dream. While most stocks never come close, some mid-cap companies possess the growth drivers, scalability, and market opportunities that could lead to outsized long-term returns.","market":"us","thumbnail":"https://thesmartinvestor.com.sg/wp-content/uploads/2025/09/Westlite-Mandai-Singapore-CAREIT-300x200.png","type":0,"news_type":0,"thumbnails":["https://thesmartinvestor.com.sg/wp-content/uploads/2025/09/Westlite-Mandai-Singapore-CAREIT-300x200.png"],"rights":{"source":"thesmartinvestor_highlight","url":"https://thesmartinvestor.com.sg/is-this-singapore-mid-cap-stock-a-10-bagger-in-the-making/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://thesmartinvestor.com.sg/is-this-singapore-mid-cap-stock-a-10-bagger-in-the-making/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"thesmartinvestor_highlight","symbols":["BK6133","PER.AU","8C8U.SI","SG9999004311.SGD","BK6520","BK7096","BK6512","BK4159","BK6082","BK6139","BK6142","OU8.SI","BK6045","SG9999014492.USD","BWCU.SI","BK6110","E3B.SI","SG9999014484.SGD","CAGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628782122","title":"CEO, MD & Director of Percheron Therapeutics James Garner Buys 40% More Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2628782122","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628782122?lang=en_us&edition=fundamental","pubTime":"2026-04-18 04:40","pubTimestamp":1776458444,"startTime":"0","endTime":"0","summary":"Whilst it may not be a huge deal, we thought it was good to see that the Percheron Therapeutics Limited ( ASX:PER...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-per/percheron-therapeutics-shares/news/ceo-md-director-of-percheron-therapeutics-james-garner-buys","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-per/percheron-therapeutics-shares/news/ceo-md-director-of-percheron-therapeutics-james-garner-buys","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4196","BK4007","PER.AU","LENZ","BK4539","MD","BK4139","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627495171","title":"Percheron Therapeutics Ltd-Results of Entitlement Offer","url":"https://stock-news.laohu8.com/highlight/detail?id=2627495171","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627495171?lang=en_us&edition=fundamental","pubTime":"2026-04-14 11:00","pubTimestamp":1776135649,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260414:nTUE1M3H2B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","PER.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624596158","title":"Bali Airport Records 1% Raise in Passengers During 2026 Eid Holiday","url":"https://stock-news.laohu8.com/highlight/detail?id=2624596158","media":"Tempo","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624596158?lang=en_us&edition=fundamental","pubTime":"2026-04-01 15:17","pubTimestamp":1775027866,"startTime":"0","endTime":"0","summary":"TEMPO.CO, Jakarta-I Gusti Ngurah Rai Airport in Bali served 1.14 million passengers during the 18-day Eid travel seasonin 2026.\"During the 18-day period of the integrated post from March 13 to 30, 2026, PT Angkasa Pura Indonesia, as the airport manager, recorded an overall 1.14 million passengers,\" said General Manager Nugroho Jati in a statement in Denpasar, Bali, on Tuesday.The airport, he said, recorded 503,000 domestic passengers and 639,000 passengers in international routes, a 1 percent raise compared to last year's Eid holiday season.","market":"sg","thumbnail":"https://statik.tempo.co/data/2026/03/04/id_1461974/1461974_720.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2026/03/04/id_1461974/1461974_720.jpg"],"rights":{"source":"tempo_highlight","url":"https://en.tempo.co/read/2095722/bali-airport-records-1-raise-in-passengers-during-2026-eid-holiday","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/2095722/bali-airport-records-1-raise-in-passengers-during-2026-eid-holiday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["PER.AU","SUB","BK7096","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619482195","title":"BRIEF-Percheron Therapeutics To Raise Up To A$2.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2619482195","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619482195?lang=en_us&edition=fundamental","pubTime":"2026-03-16 09:22","pubTimestamp":1773624136,"startTime":"0","endTime":"0","summary":"BRIEF-Percheron Therapeutics To Raise Up To A$2.2 MillionMarch 16  - Percheron Therapeutics Ltd PER.AX:NON-RENOUNCEABLE ENTITLEMENT OFFERANNOUNCES NON-RENOUNCEABLE ENTITLEMENT OFFER TO RAISE UP TO A$2.2 MILLIONISSUE PRICE SET AT A$0.005 PER SHAREFurther company coverage: PER.AX ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nTUE4NW3M4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PER.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619486221","title":"Percheron Therapeutics Ltd-Non-Renounceable Entitlement Offer","url":"https://stock-news.laohu8.com/highlight/detail?id=2619486221","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619486221?lang=en_us&edition=fundamental","pubTime":"2026-03-16 06:59","pubTimestamp":1773615569,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260315:nTUE4NW3M4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PER.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619486063","title":"Percheron Therapeutics Ltd - Issue Price Set at a$0.005 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2619486063","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619486063?lang=en_us&edition=fundamental","pubTime":"2026-03-16 06:59","pubTimestamp":1773615569,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260315:nTUE4NW3M4:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","PER.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":9,"code":"91000000","status":"200"}]}}